Jacob Puliyel has submitted that there is no reason...
Drug Controller General of India
Because its trials were so poorly designed and reported,...
Virafin's phase 2 trial has several methodological and reporting...
It's not clear which provision of the 2019 Rules...
SputnikĀ V, developed by Moscow's Gamaleya Institute, has proved 91.6%...
The approval could help health authorities minimise vaccine wastage...
Photo: Dan Asaki/Unsplash. Bengaluru: As the world scrambled to...












